V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009291 | 270005519 | 1.8 | 58 | Curative (C) | 2018-04-27 | 2018-05-12 | CVP R | N | N | 270017533 | CARBOPLATIN |
| 270009292 | 270005519 | 1.8 | 83.6 | Neo-adjuvant (N) | 2014-06-15 | 2014-06-28 | Cetuximab + Radiotherapy Load | 2 | N | 270017533 | SCOT TRIAL |
| 270009293 | 270005519 | 1.6 | null | Adjuvant (A) | null | 2017-05-21 | Cetuximab 7 day (Cycle 1) | N | N | 270017533 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009294 | 270017824 | 1.62 | 74 | Palliative (P) | null | 2016-04-07 | CETUXIMAB + IRINOTECAN + MDG | null | null | 270017561 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009295 | 270018875 | 1.7 | 63 | Palliative (P) | 2017-10-19 | 2017-10-26 | Bevacizumab + Cape + Oxali 14day | 02 | N | 270017563 | CETUXIMAB + RT |
| 270009296 | 270005520 | null | null | Adjuvant (A) | 2017-01-31 | 2017-02-15 | Chlorambucil | N | Y | 270017564 | CETUXIMAB + RT |
| 270009297 | 270005521 | 1.74 | null | Palliative (P) | 2015-04-27 | 2015-05-29 | CETUXIMAB + RT | N | N | 270017566 | SCOT TRIAL |
| 270009298 | 270005521 | 1.67 | 25.6 | Palliative (P) | null | 2016-11-26 | CAPECITABINE + OXALIPLATIN + RT | N | N | 270017566 | NOT MATCHED |
| 270009299 | 270015985 | 1.73 | null | Palliative (P) | 2015-01-29 | 2015-01-29 | CETUXIMAB + IRINOTECAN | null | null | 270017577 | DOCETAXEL |
| 270009300 | 270017825 | 1.68 | 68.9 | Palliative (P) | 2014-06-04 | 2014-06-06 | Cetuximab + Oxaliplatin + MdG Load | N | N | 270017579 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270009301 | 270017825 | 1.62 | 59.1 | Palliative (P) | 2017-01-25 | 2017-02-02 | CAP + RT | N | N | 270017579 | GEMCARBO |
| 270009302 | 270005522 | null | 79.3 | Curative (C) | null | 2016-12-27 | Carboplatin AUC 2 - 5 | N | N | 270017602 | CETUXIMAB + RT |
| 270009303 | 270005523 | 1.74 | 70 | Palliative (P) | null | 2013-05-07 | Bevacizumab + Cape + Oxali 21day | N | N | 270017611 | CETUXIMAB + IRINOTECAN + MDG |
| 270009304 | 270005524 | 1.76 | 86 | Neo-adjuvant (N) | 2013-11-29 | 2013-11-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270017622 | CARBOPLATIN + ETOPOSIDE |
| 270009305 | 270005524 | null | null | Palliative (P) | 2015-03-10 | 2015-03-16 | Cetuximab 7 day (Cycle 1) | null | null | 270017622 | CAPECITABINE + IRINOTECAN |
| 270009306 | 270005525 | 1.77 | 85.7 | Palliative (P) | 2013-08-16 | 2013-09-17 | ECX | N | Y | 270017633 | CETUXIMAB + IRINOTECAN + MDG |
| 270009307 | 270005526 | null | null | Palliative (P) | 2013-03-05 | 2013-03-14 | EPOC TRIAL | N | N | 270017635 | BEVACIZUMAB |
| 270009308 | 270005527 | 1.84 | 101 | Neo-adjuvant (N) | 2014-11-18 | 2014-11-27 | CAP + RT | N | N | 270017640 | FOXTROT TRIAL |
| 270009309 | 270005527 | null | 66.9 | Palliative (P) | 2015-03-20 | 2015-04-04 | Cetuximab + Radiotherapy Load | N | N | 270017640 | PEMBROLIZUMAB |
| 270009310 | 270005528 | 1.67 | 119 | Curative (C) | 2017-05-19 | 2017-06-02 | CETUXIMAB + RT | N | Y | 270017654 | PANITUMUMAB |
| 270009311 | 270005529 | 1.76 | 60.6 | null | 2013-03-18 | 2013-03-27 | Cetuximab + FLUOROURACIL | N | N | 270017657 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270009312 | 270012745 | 1.78 | 72.6 | Palliative (P) | 2015-05-26 | 2015-06-13 | Enzalutamide | N | N | 270017658 | ENZALUTAMIDE |
| 270009313 | 270012745 | 1.65 | 75 | Curative (C) | 2014-09-01 | 2014-09-28 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270017658 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009314 | 270012745 | 1.63 | null | Palliative (P) | 2013-12-30 | 2014-01-02 | Bevacizumab + Cape + Oxali 21day | N | N | 270017658 | GEMCARBO |
| 270009315 | 270005530 | 1.7 | 0 | Palliative (P) | 2015-01-05 | 2014-12-08 | CARBOPLATIN + PACLITAXEL | N | N | 270017664 | CARBOPLATIN + RT |
| 270009316 | 270005531 | 1.73 | 68 | Palliative (P) | 2017-10-17 | 2017-10-19 | Cisplatin + Pemetrexed | 02 | N | 270017665 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009317 | 270005531 | 1.73 | 56.7 | null | 2013-10-10 | 2013-10-12 | Bevacizumab 7.5mg/kg | N | N | 270017665 | DOCETAXEL |
| 270009318 | 270005532 | 0 | 62 | null | 2013-11-22 | 2013-11-29 | Cisplatin + Pemetrexed | N | N | 270017681 | GEMCITABINE |
| 270009319 | 270005533 | 1.65 | 55.1 | Palliative (P) | 2016-10-26 | 2016-11-11 | ECF | N | null | 270017686 | CARBOPLATIN |
| 270009320 | 270005534 | 1.67 | 76.5 | Adjuvant (A) | 2013-08-10 | 2013-08-23 | Carboplatin AUC 2 - 5 | Y | N | 270017687 | CETUXIMAB |
| 270009321 | 270005535 | 1.55 | 126 | Curative (C) | 2013-04-21 | 2013-09-02 | CETUXIMAB | 02 | N | 270017701 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009322 | 270012747 | 1.73 | 45.6 | Curative (C) | 2016-07-11 | 2016-07-14 | Cisplatin + Fluorouracil + RT 5day | N | N | 270017717 | CETUXIMAB + RT |
| 270009323 | 270012747 | null | 128 | Not known (9) | 2014-09-03 | 2014-09-06 | CARBOPLATIN + RT | 02 | N | 270017717 | CETUXIMAB |
| 270009324 | 270005536 | 1.93 | 53 | Palliative (P) | 2013-02-18 | 2013-02-18 | Bevacizumab + Oxaliplatin +MdG | N | N | 270017728 | DOCETAXEL |
| 270009325 | 270005537 | null | 65 | Palliative (P) | 2017-05-09 | 2017-05-16 | Capecitabine (14 day) + Irinotecan | N | N | 270017744 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270009326 | 270005538 | 1.62 | null | Not known (9) | 2015-04-03 | 2015-04-10 | GemCarbo Days 1+8 | 02 | N | 270017751 | CAPE + CARBOPLATIN + CETUXIMAB |
| 270009327 | 270005539 | 1.59 | 58 | Palliative (P) | 2013-10-20 | 2013-11-02 | Bevacizumab 7.5mg/kg | 02 | N | 270017754 | EOX |
| 270009328 | 270005539 | 1.59 | 78 | Curative (C) | 2015-06-29 | 2015-07-03 | Carboplatin AUC 2 - 5 | 02 | N | 270017754 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270009329 | 270005539 | 0 | 51 | Palliative (P) | 2016-03-09 | 2016-03-22 | CETUXIMAB + IRINOTECAN | N | N | 270017754 | IRINOTECAN + PANITUMUMAB + MDG |
| 270009330 | 270005540 | 1.75 | null | Palliative (P) | 2016-03-11 | 2016-03-25 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | 2 | N | 270017775 | CISPLATIN + VINORELBINE |
| 270009331 | 270005541 | 1.67 | 66.2 | Curative (C) | 2014-04-10 | 2014-04-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 270017777 | CETUXIMAB + RT |
| 270009332 | 270005542 | 1.77 | 66 | Adjuvant (A) | 2017-06-13 | 2018-01-15 | Carboplatin AUC 2 - 5 | N | N | 270017781 | CETUXIMAB |
| 270009333 | 270012749 | null | null | Palliative (P) | 2013-03-28 | 2013-04-02 | Bevacizumab + Oxaliplatin +MdG | N | N | 270017783 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009335 | 270005544 | 1.65 | 67.4 | Palliative (P) | 2017-08-28 | 2017-09-16 | Cetuximab 7 day (>Cycle 2) | Y | N | 270017785 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270009336 | 270005545 | 1.73 | null | null | 2017-09-17 | 2017-09-28 | FLUOROURACIL + MITOMYCIN + RT | null | null | 270017787 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009338 | 270005546 | 1.7 | 72 | Curative (C) | 2017-10-03 | 2017-10-03 | Cetuximab + Radiotherapy Load | N | N | 270017792 | IMATINIB |
| 270009339 | 270005547 | 1.63 | 95 | Palliative (P) | 2014-04-27 | 2014-05-03 | Cetuximab + Radiotherapy Load | N | Y | 270017800 | GEMCITABINE |
| 270009340 | 270005547 | 1.84 | 67.8 | Curative (C) | 2016-11-18 | 2016-11-25 | Cetuximab 7 day (Cycle 1) | N | N | 270017800 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270009341 | 270015989 | null | 95 | null | 2015-09-18 | 2015-09-22 | CETUXIMAB | 02 | N | 270017811 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009342 | 270017827 | 1.72 | 68.3 | null | null | 2016-05-04 | Folfirinox | N | N | 270017815 | CETUXIMAB + OXALIPLATIN + MDG |